Year: 2019

Paris, France and Camberley, UK – 16 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme announced on 23 April 2019, it has issued a tranche of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma Group

Paris, France et Camberley, UK – 9 juillet 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT) annonce qu’en vertu du programme de financement par des Obligations Convertibles assorties de warrants annoncé le 23 avril 2019, elle a émis une tranche d’actions ordinaires nouvelles de 1/15ème d’euro chacune (« Actions Ordinaires ») à

Paris, France and Camberley, UK – 9 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme announced on 23 April 2019, it has issued a tranche of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma Group

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers http://novacyt.com/wp-content/uploads/2019/07/NOVACYT_CP_Droits-de-vote_2019-Juillet.pdf

Paris, France et Camberley, Royaume-Uni – 1 juillet 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), un spécialiste international du diagnostic clinique, publie aujourd’hui le bilan mensuel du nombre d’actions échangées au titre du contrat de liquidité confié à Invest Securities SA (le « Contrat de liquidité »). http://novacyt.com/wp-content/uploads/2019/07/Contrat-de-liquidité-1-juillet-2019.

Paris, France and Camberley, UK – 1 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). http://novacyt.com/wp-content/uploads/2019/07/Liquidity-Agreement-1-July-2019.pdf

Paris, France and Camberley, UK – 1 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised

Paris, France et Camberley, UK – 28 juin 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT) annonce qu’en vertu du programme de financement par des Obligations Convertibles assorties de warrants annoncé le 23 avril 2019, elle a émis une tranche d’actions ordinaires nouvelles de 1/15ème d’euro chacune (« Actions Ordinaires ») à

Paris, France and Camberley, UK – 28 June 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme announced on 23 April 2019, it has issued a tranche of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma Group

Paris, France and Camberley, UK – 26 June 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces that further to the announcement on 20 June 2019, the Company confirms that the location of the Annual General and Extraordinary General Shareholders’ Meeting will be held on 18th July 2019